In the cancer context, the TGF-β opposing activity of BMP-7 is again highlighted as major contributor to beneficial outcome, e.g. by inhibiting TGF-β-driven development of invasive cancer via downregulation of integrin β3 expression (Naber et al. 2012). The gene discussed is TGFB1; the disease is cancer.